You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)向控股股東收購上海復拓餘下49%股權
復星醫藥(02196.HK)(600196.SH)公布,擬以4.02億元人民幣現金向公司控股股東復星高科技附屬復星健控收購上海復拓股權。目前公司及復星健控分別持有上海復拓51%及49%股權。收購完成後,公司持有上海復拓的股權比例將由51%增至100%。 上海復拓持有的控股資產包括復星領智及下屬四個孵化企業,以及從事微創醫療器械研發的復拓知達。復星領智是集團旗下的科創孵化平台,目前已孵化企業包括上海精繕生物科技(主要從事基因細胞治療產品的開發)、上海菌濟健康科技(主要從事微生態菌群產品的開發)、杭州深愛科技(主要從事腫瘤精準治療人工智能算法的開發)、杭州星(月太)原生物技術(主要從事個性化腫瘤免疫治療產品的開發)4家科創公司,並與復旦大學附屬華山醫院、復旦大學附屬中山醫院、芝加哥大學、西湖大學、復旦大學等相關醫療機構、高校和研究所建立了緊密的合作關係。 目前上海精繕生物科技已有一項產品向國家藥品監督管理局提交臨床試驗申請(IND),其他3家公司的產品研發尚處於早期階段。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account